Crossref journal-article
Ovid Technologies (Wolters Kluwer Health)
Circulation (276)
Abstract

BackgroundIbutilide is an action potential–prolonging antiarrhythmic currently in clinical trials. The drug shares structural similarities with E-4031 and dofetilide, specific blockers of the rapidly activating delayed rectifier K+current (IKr). However, previous in vitro studies in guinea pig myocytes have indicated that ibutilide does not block IKrbut rather increases a slow inward sodium current.Methods and ResultsIn this study, we compared the effects of ibutilide with those of dofetilide on outward current in mouse atrial tumor myocytes (AT-1 cells), a preparation in which, unlike guinea pig, a typical IKris the major delayed rectifier and can be readily recorded in isolation from other currents. In AT-1 cells, ibutilide and dofetilide were both potent IKrblockers, with EC50values of 20 (n=12) and 12 (n=8) nmol/L, respectively, at +20 mV. The time and voltage dependence of IKrinhibition by the two compounds were virtually identical. The following characteristics were most consistent with open channel block: (1) block increased with depolarizing pulses; (2) block increased with longer pulses; (3) currents deactivated more slowly in the presence of drug, resulting in a “crossover” typical of open channel block; and (4) with repetitive pulsing after drug wash-in, use-dependent block was observed.ConclusionsThese data suggest that the clinical actions of ibutilide are mediated at least in part by block of IKr; an effect on inward currents is not excluded. AT-1 cells are a useful model system for the study of drug block of this important repolarizing current.

Bibliography

Yang, T., Snyders, D. J., & Roden, D. M. (1995). Ibutilide, a Methanesulfonanilide Antiarrhythmic, Is a Potent Blocker of the Rapidly Activating Delayed Rectifier K+Current (IKr) in AT-1 Cells. Circulation, 91(6), 1799–1806.

Authors 3
  1. Tao Yang (first)
  2. Dirk J. Snyders (additional)
  3. Dan M. Roden (additional)
References 35 Referenced 150
  1. 10.1161/circ.82.6.2242545
  2. 10.1016/0002-9149(93)90236-6
  3. Singh BN. Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact. Eur Heart J. 1993;14(suppl H):14-23. (10.1093/eurheartj/14.suppl_H.14)
  4. 10.1085/jgp.96.1.195
  5. 10.1161/circ.82.1.2114236
  6. Carmeliet E. Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide. J Pharmacol Exp Ther. 1992;262:809-817. (10.1016/S0022-3565(25)10827-6) / J Pharmacol Exp Ther (1992)
  7. 10.1161/res.75.5.7923633
  8. 10.1126/science.2964082
  9. Steinhelper ME, Lanson NA Jr, Dresdner KP, Delcarpio JB, Wit AL, Claycomb WC, Field LJ. Proliferation in vivo and in culture of differentiated adult atrial cardiomyocytes from transgenic mice. Am J Physiol. 1990;259:H1826-H1834. / Am J Physiol (1990)
  10. 10.1161/res.69.6.1954678
  11. 10.1016/0014-2999(92)90467-I
  12. Buchanan LV, Kabell G, Brunden MN, Gibson JK. Comparative assessment of ibutilide, d-sotalol, clofilium, E-4031 and UK-68,798 in a rabbit model of proarrhythmia. J Cardiovasc Pharmacol. 1993;22:540-549. / J Cardiovasc Pharmacol (1993)
  13. DiMarco JP, The Ibutilide for Atrial Arrhythmias Study Group. Cardioversion of atrial flutter by intravenous ibutilide, a new class III antiarrhythmic agent. J Am Coll Cardiol. 1991;17:324A. Abstract. / J Am Coll Cardiol (1991)
  14. Lee KS. Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in guinea pig ventricular cells. J Pharmacol Exp Ther. 1992;262:99-108. (10.1016/S0022-3565(25)10779-9) / J Pharmacol Exp Ther (1992)
  15. 10.1007/BF00656997
  16. 10.1007/BF00582522
  17. 10.1126/science.2543073
  18. 10.1113/jphysiol.1987.sp016571
  19. 10.1085/jgp.96.4.835
  20. Snyders DJ, Knoth KM, Roberds SL, Tamkun MM. Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel. Mol Pharmacol. 1992;41:322-330. (10.1016/S0026-895X(25)08880-7) / Mol Pharmacol (1992)
  21. 10.1016/0014-2999(93)90704-L
  22. Wesley RC Jr, Farkhani F, Morgan D, Zimmerman D. Ibutilide: enhanced defibrillation via plateau sodium current activation. Am J Physiol. 1993;264:H1269-H1274. / Am J Physiol (1993)
  23. 10.1161/01.RES.72.1.75
  24. 10.1161/res.68.1.1984874
  25. Lynch JJ Jr, Wallace AA, Van der Gaag LH, Baskin EP, Bear CM, Gehret JR, Kothstein T, Stupienski RF, Appleby SD, Sanguinetti MC. Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1′-[2-(benzofurazan-5-yl)ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4′-piperidin]-4-one HCl (L-691,121), a novel class III agent. J Pharmacol Exp Ther. 1993;265:720-730. (10.1016/S0022-3565(25)38200-5) / J Pharmacol Exp Ther (1993)
  26. Carmeliet E. Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers. J Pharmacol Exp Ther. 1985;232:817-825. (10.1016/S0022-3565(25)20919-3) / J Pharmacol Exp Ther (1985)
  27. 10.1161/circ.79.5.2469545
  28. 10.1097/00005344-199008000-00019
  29. 10.1016/S0735-1097(87)80389-3
  30. Echt DS Lee JT Murray KT Vorperian V Borganelli SM Crawford DM Roden DM. A randomized double-blind placebo-controlled dose-ranging study of intravenous UK-68 798 (dofetilide) in patients with inducible sustained ventricular tachyarrhythmias. Circulation. 1991;84(suppl II):II-714. Abstract.
  31. 10.1016/0002-8703(93)90726-P
  32. Hohnloser SH, Arendts W, Quart B, Bristol Myers Squibb Research Institute. Incidence, type, and dose-dependence of proarrhythmic events during sotalol therapy in patients treated for sustained VT/VF. PACE Pacing Clin Electrophysiol. 1992;15:551. Abstract. / PACE Pacing Clin Electrophysiol (1992)
  33. 10.1016/0002-9149(92)91306-O
  34. Sanguinetti MC, Jurkiewicz NK. Lanthanum blocks a specific component of IK and screens membrane surface change in cardiac cells. Am J Physiol. 1990;259:H1881-H1889. / Am J Physiol (1990)
  35. 10.1161/res.69.2.1860189
Dates
Type When
Created 13 years, 2 months ago (June 11, 2012, 8:34 p.m.)
Deposited 5 months ago (March 30, 2025, 4:51 p.m.)
Indexed 1 month, 4 weeks ago (July 6, 2025, 1:45 p.m.)
Issued 30 years, 5 months ago (March 15, 1995)
Published 30 years, 5 months ago (March 15, 1995)
Published Print 30 years, 5 months ago (March 15, 1995)
Funders 0

None

@article{Yang_1995, title={Ibutilide, a Methanesulfonanilide Antiarrhythmic, Is a Potent Blocker of the Rapidly Activating Delayed Rectifier K+Current (IKr) in AT-1 Cells: Concentration-, Time-, Voltage-, and Use-Dependent Effects}, volume={91}, ISSN={1524-4539}, url={http://dx.doi.org/10.1161/01.cir.91.6.1799}, DOI={10.1161/01.cir.91.6.1799}, number={6}, journal={Circulation}, publisher={Ovid Technologies (Wolters Kluwer Health)}, author={Yang, Tao and Snyders, Dirk J. and Roden, Dan M.}, year={1995}, month=mar, pages={1799–1806} }